This edition of DermWireTV brings news that Joseph C. Papa has left Perrigo Company plc, a top five global over-the-counter consumer goods and pharmaceutical company, to take the helm as CEO at Valeant Pharmaceuticals. He will replace J. Micheal Pearson. Valeant also concluded its investigation around Philidor. Johnson & Johnson will acquire skincare company Neostrata, which pioneered alpha hydroxy acid (AHA) based skincare. Data for Galderma's Epiduo Forte Gel show benefit for the once-daily topical treatment of patients with moderate to severe acne. Plus, new data from the American Society of Plastic Surgeons shows that desire for lips like Jennifer Lawrence, Angelina Jolie, and Beyonce is driving demand for lip enhancement procedures.